AEterna Zentaris Inc. acquires Multichem
Multichem is a privately-held Canadian company specialized in the marketing of active ingredients and specialty chemicals.
26/01/05 AEterna Zentaris Inc. has acquired all Multichem assets by its subsidiary Atrium Biotechnologies Inc., for a total amount of 23.8 million Canadian dollars. Multichem is a privately-held Canadian company specialized in the marketing of active ingredients and specialty chemicals. “The Multichem acquisition will allow them to significantly increase their presence on the North American market in the active ingredients and specialty chemicals”, said Luc Dupont, President and Chief Executive Officer of Atrium. “Furthermore, it is part of our growth strategy aimed at positioning Atrium among the leaders at the international level, in both our activity sectors which are Active Ingredients & Specialty Chemicals, as well as Health & Nutrition”; Gilles Gagnon, President and Chief Executive Officer at AEterna Zentaris added.AEterna Zentaris Inc. is an oncology and endocrine therapy focused biopharmaceutical company with proven expertise in drug discovery, development and commercialization.
